Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Vallish Bn"'
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S399-S399
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S386-S386
Autor:
Ali Hashmi, MA, Hussain, SF, Kachigalla, N, Rafiuddin, M, Bhavanasai, S, Pesara, NS, Kaushik, M, Jan, R, Vallish, BN, Dang, A
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S478-S478
Autor:
Vallish, BN, Dang, A
Publikováno v:
In Value in Health December 2022 25(12) Supplement:S452-S453
Publikováno v:
International Journal of Basic and Clinical Pharmacology. :2403-2406
Background: Despite being illegal, non-prescription sales of antibiotics in India continue to be a major contributor to antibiotic abuse, which fosters antibiotic resistance. Methods: Two trained actors simulated symptoms of acute gastroenteritis (AG
Autor:
Dhivya Thiyagarajan, Vallish Bn, Brahadeesh Mayathevar, S A Rizwan, Thamilarasi Soundararajan
Publikováno v:
International Journal of Basic and Clinical Pharmacology.
Background: To determine the incidence of Adverse drug reactions in our hospital, to study the age wise distribution, the role of concurrent medication and the common drugs that are prone to cause adverse drug reactions and its seriousness. Methods:
Autor:
Abhijeet D Joshi, Vallish Bn, Shyamal R Sinha, Raj Kishore Mahato, Avinash V Turankar, Sadiq B Patel
Publikováno v:
Journal of Young Pharmacists. 6:32-36
Background: Presently available anti-seizure drugs cannot control seizures in 20-40% epilepsy patients who develop refractory epilepsy. None of the currently available anti-seizure drugs target hypersynchronization of epileptogenic impulses. Process
Publikováno v:
IOSR Journal of Pharmacy (IOSRPHR). 1:15-21
Background: Several in-vitro, animal and clinical studies have reported anti-inflammatory activity of macrolides. Antiinflammatory properties of macrolides form the basis for their experimental use in airway inflammatory and infective conditions like
Autor:
Dang A; MarksMan Healthcare Communications, Hyderabad, Telangana, India., Dang D; MarksMan Healthcare Communications, Hyderabad, Telangana, India., Vallish BN; MarksMan Healthcare Communications, Hyderabad, Telangana, India.
Publikováno v:
The Indian journal of medical research [Indian J Med Res] 2023 Jan; Vol. 157 (1), pp. 11-22.
Autor:
Vallish BN; Medical Writing and Biostatistics, MarksMan Healthcare Communications, Hyderabad 500091, Telangana, India., Dang D; Co-founder, MarksMan Healthcare Communications, Hyderabad 500032, Telangana, India., Dang A; Founder and CEO, MarksMan Helathcare Communications Pvt. Ltd, Hyderabad 500091, Telangana, India. amit.d@marksmanhealthcare.com.
Publikováno v:
World journal of methodology [World J Methodol] 2022 May 20; Vol. 12 (3), pp. 132-147. Date of Electronic Publication: 2022 May 20 (Print Publication: 2022).